Revelation Total Liab vs Accounts Payable Analysis
| REVBW Stock | USD 0.01 0 16.50% |
Revelation Biosciences financial indicator trend analysis is much more than just breaking down Revelation Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Revelation Biosciences is a good investment. Please check the relationship between Revelation Biosciences Total Liab and its Accounts Payable accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.
Total Liab vs Accounts Payable
Total Liab vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Revelation Biosciences Total Liab account and Accounts Payable. At this time, the significance of the direction appears to have very week relationship.
The correlation between Revelation Biosciences' Total Liab and Accounts Payable is 0.22. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Revelation Biosciences, assuming nothing else is changed. The correlation between historical values of Revelation Biosciences' Total Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Revelation Biosciences are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Liab i.e., Revelation Biosciences' Total Liab and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.22 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Accounts Payable
An accounting item on the balance sheet that represents Revelation Biosciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Revelation Biosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from Revelation Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Revelation Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.At this time, Revelation Biosciences' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 94.48 in 2024, whereas Selling General Administrative is likely to drop slightly above 4.2 M in 2024.
| 2010 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 16.8K | 25.0K | 25.0K | 24.5K | Cost Of Revenue | 69.2K | 40.0K | 25.0K | 35.8K |
Revelation Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Revelation Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.